insights_auto
Why is PEB down 2.17%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.22
arrow_downward
-2.17%(-0.0050) 1D
Nov 16, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
Investing.com
·
8 minutes ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 hour ago
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
32 minutes ago
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
1 hour ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com